Current Australian clinical practice in use of botulinum toxin-A to manage paediatric hypertonicity

Journal article


O'Flaherty, Stephen J and Stewart, Kirsty. (2021). Current Australian clinical practice in use of botulinum toxin-A to manage paediatric hypertonicity. Journal of Paediatrics and Child Health. 57(10), pp. 1662-1665. https://doi.org/10.1111/jpc.15589
AuthorsO'Flaherty, Stephen J and Stewart, Kirsty
Abstract

Aim
To describe current rehabilitation paediatricians' use of intramuscular botulinum toxin-A (BoNT-A) to manage hypertonicity.

Methods
Cross-sectional survey.

Results
In late 2019, 32 of the 35 identified Australian rehabilitation paediatricians who use BoNT-A to manage paediatric hypertonicity completed the survey. Annually, they administer just over 3750 courses of BoNT-A to manage hypertonicity with a mean of 11 years of clinical experience. Sedation was used by all but 1 clinician who used a number of other strategies during the procedure. Mean (and median) maximum dose of OnabotulinumtoxinA (Botox) was 400 Units (range 300–450 Units). Only three clinicians indicated that they used AbobotulinumtoxinA (Dysport) – the other BoNT-A preparation approved for children available in Australia; analysis of its use was not performed. Dose modifications were made by clinicians according to a patient's response to a previous course of BoNT-A (88% of respondents); patient experience of a previous adverse event (78%); history of aspiration or dysphagia (65 and 63%, respectively); and the presence of dystonia; and where the patient was GMFCS level V (53% each). Intervals between courses ranged from 3 to 24 months with the variation due to clinical circumstances.

Conclusion
Clinical practice in BoNT-A management of paediatric hypertonicity was largely consistent in regard to maximum doses of OnabotulinumtoxinA (Botox) used. Dose modification and time between injection courses varied according to individual clinical presentation. Procedural sedation was used extensively.

Keywordsbotulinum toxin-A; hypertonicity; paediatric
Year2021
JournalJournal of Paediatrics and Child Health
Journal of Paediatrics and Child Health
Journal citation57 (10), pp. 1662-1665
PublisherBlackwell Publishing
ISSN1034-4810
Digital Object Identifier (DOI)https://doi.org/10.1111/jpc.15589
PubMed ID34036660
Scopus EID2-s2.0-85106417529
Research or scholarlyResearch
Page range1662-1665
Publisher's version
License
All rights reserved
File Access Level
Controlled
Output statusPublished
Publication dates
Online23 May 2021
Publication process dates
Accepted16 May 2021
Deposited09 Nov 2021
Permalink -

https://acuresearchbank.acu.edu.au/item/8x043/current-australian-clinical-practice-in-use-of-botulinum-toxin-a-to-manage-paediatric-hypertonicity

Restricted files

Publisher's version

  • 94
    total views
  • 0
    total downloads
  • 0
    views this month
  • 0
    downloads this month
These values are for the period from 19th October 2020, when this repository was created.

Export as

Related outputs

Caregiver perspectives of scoliosis surgery for children with cerebral palsy : a qualitative study
Stewart, Kirsty, Price, Georgia, Kelderman, Jayne, Carman, Sarah, Imms, Christine and Wallen, Margaret. (2024). Caregiver perspectives of scoliosis surgery for children with cerebral palsy : a qualitative study. Disability and Rehabilitation. pp. 1-10. https://doi.org/10.1080/09638288.2024.2342501
The Dyskinetic Cerebral Palsy Functional Impact Scale : Development and validation of a new tool
Stewart, Kirsty, Lewis, Jennifer, Wallen, Margaret, Bear, Natasha and Harvey, Adrienne. (2021). The Dyskinetic Cerebral Palsy Functional Impact Scale : Development and validation of a new tool. Developmental Medicine and Child Neurology. 63(12), pp. 1469-1475. https://doi.org/10.1111/dmcn.14960
The impact of intrathecal baclofen therapy on health-related quality of life for children with marked hypertonia
Stewart, Kirsty, Copeland, Lisa and Lewis, Jennifer. (2020). The impact of intrathecal baclofen therapy on health-related quality of life for children with marked hypertonia. Developmental Neurorehabilitation. 23(8), pp. 542-547. https://doi.org/10.1080/17518423.2020.1753841
Implementing accurate identification and measurement of dyskinesia in cerebral palsy into clinical practice : A knowledge translation study
Stewart, Kirsty, de Vries, Tessa and Harvey, Adrienne. (2019). Implementing accurate identification and measurement of dyskinesia in cerebral palsy into clinical practice : A knowledge translation study. Journal of Paediatrics and Child Health. 55(11), pp. 1351-1356. https://doi.org/10.1111/jpc.14420
Intrathecal baclofen therapy in children : An analysis of individualized goals
Liew, Peck Yee, Stewart, Kirsty, Khan, Debra, Arnup, Sarah Jane and Scheinberg, Adam. (2018). Intrathecal baclofen therapy in children : An analysis of individualized goals. 60(4), pp. 367-373. https://doi.org/10.1111/dmcn.13660
Identification, classification and assessment of dyskinesia in children with cerebral palsy : A survey of clinicians
Stewart, Kirsty, Tavender, Emma, Rice, James and Harvey, Adrienne. (2018). Identification, classification and assessment of dyskinesia in children with cerebral palsy : A survey of clinicians. Journal of Paediatrics and Child Health. 54(4), pp. 432-438. https://doi.org/10.1111/jpc.13749
Intrathecal baclofen therapy in paediatrics : A study protocol for an Australian multicentre, 10-year prospective audit
Stewart, Kirsty, Hutana, Gavin and Kentish, Megan. (2017). Intrathecal baclofen therapy in paediatrics : A study protocol for an Australian multicentre, 10-year prospective audit. BMJ Open. 7(6), p. Article e015863. https://doi.org/10.1136/bmjopen-2017-015863
Using family and staff experiences of a botulinum toxin-A service to improve service quality
Burton, K. L. O., Bau, K., Lewis, J., Aroyan, K. R., Botha, B., Botman, A. G. M., Stewart, K., Waugh, M. C. A. and Paget, S. P.. (2017). Using family and staff experiences of a botulinum toxin-A service to improve service quality. Child: Care, Health and Development. 43(6), pp. 847-853. https://doi.org/10.1111/cch.12500
A systematic review of scales to measure dystonia and choreoathetosis in children with dyskinetic cerebral palsy
Stewart, Kirsty, Harvey, Adrienne and Johnston, Leanne M.. (2017). A systematic review of scales to measure dystonia and choreoathetosis in children with dyskinetic cerebral palsy. Developmental Medicine and Child Neurology. 59(8), pp. 786-795. https://doi.org/10.1111/dmcn.13452
Grading and quantification of upper extremity function in children with spasticity
Wallen, Margaret and Stewart, Kirsty. (2016). Grading and quantification of upper extremity function in children with spasticity. Seminars in Plastic Surgery. 30(1), pp. 5 - 13. https://doi.org/10.1055/s-0035-1571257
Upper limb function in everyday life of children with cerebral palsy: Description and review of parent report measures
Wallen, Margaret and Stewart, Kirsty. (2015). Upper limb function in everyday life of children with cerebral palsy: Description and review of parent report measures. Disability and Rehabilitation. 37(15), pp. 1353 - 1361. https://doi.org/10.3109/09638288.2014.963704